Document and Entity Information
Document and Entity Information | 12 Months Ended |
Apr. 30, 2021 | |
Cover [Abstract] | |
Entity Registrant Name | Slinger Bag Inc. |
Entity Central Index Key | 0001674440 |
Document Type | S-1 |
Amendment Flag | false |
Entity Filer Category | Non-accelerated Filer |
Entity Small Business Flag | true |
Entity Emerging Growth Company | true |
Entity Ex Transition Period | false |
Consolidated Balance Sheets
Consolidated Balance Sheets - USD ($) | Apr. 30, 2021 | Apr. 30, 2020 |
Current assets | ||
Cash and cash equivalents | $ 928,796 | $ 79,847 |
Accounts receivable, net | 762,487 | |
Inventories, net | 3,693,216 | 919,644 |
Prepaid expenses and other current assets | 200,160 | 381,510 |
Total current assets | 5,584,659 | 1,381,001 |
Intangible asset, net | 112,853 | |
Total assets | 5,697,512 | 1,381,001 |
Current liabilities | ||
Accounts payable and accrued expenses | 2,050,476 | 1,108,488 |
Accrued payroll and bonuses | 1,283,464 | 257,730 |
Deferred revenue | 99,531 | 179,366 |
Accrued interest - related party | 747,636 | 138,967 |
Notes payable - related party, net | 6,143,223 | 2,100,000 |
Convertible notes payable, net | 82,128 | |
Derivative liabilities | 13,813,449 | 620,238 |
Total current liabilities | 24,137,779 | 4,486,917 |
Long-term liabilities | ||
Long-term portion of convertible notes payable, net | 1,493,939 | |
Notes payable, net | 10,477 | 393,975 |
Total liabilities | 24,148,256 | 6,374,831 |
Commitments and contingencies (Note 10) | ||
Shareholders' deficit | ||
Common stock, $0.001 par value, 300,000,000 shares authorized, 27,642,828 and 24,749,354 shares issued and outstanding as of April 30, 2021 and 2020, respectively; 6,921,299 and 8,137,859 shares issuable as of April 30, 2021 and 2020, respectively | 27,643 | 24,749 |
Additional paid-in capital | 10,365,056 | 5,214,970 |
Accumulated other comprehensive loss | (20,170) | (5,036) |
Accumulated deficit | (28,823,273) | (10,228,513) |
Total shareholders' deficit | (18,450,744) | (4,993,830) |
Total liabilities and shareholders' deficit | $ 5,697,512 | $ 1,381,001 |
Consolidated Balance Sheets (Pa
Consolidated Balance Sheets (Parenthetical) - $ / shares | Apr. 30, 2021 | May 06, 2020 | Apr. 30, 2020 | Feb. 25, 2020 | Feb. 24, 2020 |
Statement of Financial Position [Abstract] | |||||
Common stock, par value | $ 0.001 | $ 0.001 | |||
Common stock, shares authorized | 300,000,000 | 300,000,000 | 300,000,000 | 75,000,000 | |
Common stock, shares issued | 27,642,828 | 1,216,560 | 24,749,354 | ||
Common stock, shares outstanding | 27,642,828 | 24,749,354 | |||
Shares issuable | 6,921,299 | 8,137,859 |
Consolidated Statements of Oper
Consolidated Statements of Operations and Comprehensive Loss - USD ($) | 12 Months Ended | |
Apr. 30, 2021 | Apr. 30, 2020 | |
Income Statement [Abstract] | ||
Net sales | $ 10,804,214 | $ 686,179 |
Cost of sales | 7,680,290 | 1,370,897 |
Gross income (loss) | 3,123,924 | (684,718) |
Operating expenses: | ||
Selling and marketing expenses | 1,761,154 | 563,003 |
General and administrative expenses | 4,749,922 | 5,291,075 |
Research and development costs | 339,385 | 179,982 |
Transaction costs | 198,443 | |
Total operating expenses | 6,850,461 | 6,232,503 |
Loss from operations | (3,726,537) | (6,917,221) |
Other expenses (income): | ||
Amortization of debt discount | 376,506 | 1,565,174 |
Loss on extinguishment of debt | 3,030,495 | |
Induced conversion loss | 51,412 | |
Gain on change in fair value of derivatives | (1,939,639) | |
Interest expense - related party | 608,668 | 171,918 |
Interest expense | 12,740,781 | 573,431 |
Total other expense | 14,868,223 | 2,310,523 |
Loss before income taxes | (18,594,760) | (9,227,744) |
Provision for income taxes | ||
Net loss | (18,594,760) | (9,227,744) |
Other comprehensive loss, net of tax | ||
Foreign currency translation adjustments | (15,134) | (5,034) |
Total other comprehensive loss, net of tax | (15,134) | (5,034) |
Comprehensive loss | $ (18,609,894) | $ (9,232,778) |
Net loss per share, basic and diluted | $ (0.70) | $ (0.37) |
Weighted average number of common shares outstanding, basic and diluted | 26,723,038 | 24,689,813 |
Consolidated Statements of Shar
Consolidated Statements of Shareholders' Deficit - USD ($) | Common Stock [Member] | Additional Paid-in Capital [Member] | Accumulated Other Comprehensive Loss [Member] | Accumulated Deficit [Member] | Total |
Balance at Apr. 30, 2019 | $ 24,380 | $ 2,520 | $ (33,091) | $ (6,191) | |
Balance, shares at Apr. 30, 2019 | 24,380,000 | ||||
Contribution of Slinger Bag Limited | (2) | (967,678) | (967,680) | ||
Shares issuable related to note payable | 1,492,188 | 1,492,188 | |||
Distribution to shareholder | (332,239) | (332,239) | |||
Forgiveness of net liabilities owed to former majority shareholder | 15,289 | 15,289 | |||
Shares issued in connection with conversion of debt | $ 369 | 182,476 | |||
Shares issued in connection with conversion of debt, shares | 369,354 | ||||
Share-based compensation | 3,741,746 | 3,741,746 | |||
Warrants issued with notes payable | 112,990 | 112,990 | |||
Foreign currency translation | (5,034) | (5,034) | |||
Net loss | (9,227,744) | (9,227,744) | |||
Balance at Apr. 30, 2020 | $ 24,749 | 5,214,970 | (5,036) | (10,228,513) | (4,993,830) |
Balance, shares at Apr. 30, 2020 | 24,749,354 | ||||
Shares issued related to note payable | $ 1,217 | (1,217) | |||
Shares issued related to note payable, shares | 1,216,560 | ||||
Forgiveness of net liabilities owed to former majority shareholder | |||||
Shares issued in connection with conversion of debt | $ 300 | 238,149 | 238,449 | ||
Shares issued in connection with conversion of debt, shares | 300,000 | ||||
Shares issued in connection with conversion of note payable | $ 772 | 1,749,232 | 1,750,004 | ||
Shares issued in connection with conversion of note payable, shares | 772,332 | ||||
Shares issued in connection with purchase of trademark | $ 35 | 35,316 | 35,351 | ||
Shares issued in connection with purchase of trademark, shares | 35,000 | ||||
Warrants issued in connection with purchase of trademark | 50,232 | 50,232 | |||
Warrants issued related to notes payable - related party | 2,157,818 | 2,157,818 | |||
Shares issued in connection with services | $ 570 | 849,559 | 850,129 | ||
Shares issued in connection with services, shares | 569,582 | ||||
Share-based compensation | 70,997 | 70,997 | |||
Foreign currency translation | (15,134) | (15,134) | |||
Net loss | (18,594,760) | (18,594,760) | |||
Balance at Apr. 30, 2021 | $ 27,643 | $ 10,365,056 | $ (20,170) | $ (28,823,273) | $ (18,450,744) |
Balance, shares at Apr. 30, 2021 | 27,642,828 |
Consolidated Statements of Cash
Consolidated Statements of Cash Flows - USD ($) | 12 Months Ended | |
Apr. 30, 2021 | Apr. 30, 2020 | |
Cash flows from operating activities: | ||
Net loss | $ (18,594,760) | $ (9,227,744) |
Adjustments to reconcile net loss to net cash used in operating activities: | ||
Depreciation and amortization expense | 2,730 | 650 |
Gain on change in fair value of derivatives | (1,939,639) | |
Shares issued in connection with services | 798,351 | |
Share-based compensation | 70,997 | 3,741,746 |
Loss on extinguishment of debt | 3,030,495 | |
Induced conversion loss | 51,412 | |
Non-cash interest expense | 12,501,178 | 358,855 |
Amortization of debt discount | 376,506 | 1,565,174 |
Changes in operating assets and liabilities: | ||
Accounts receivable, net | (760,058) | |
Inventories, net | (2,764,758) | (919,644) |
Prepaid expenses and other current assets | 208,806 | (381,510) |
Accounts payable and accrued expenses | 946,716 | 855,853 |
Accrued payroll and bonuses | 1,025,734 | 365,787 |
Deferred revenue | (79,835) | (706,408) |
Accrued interest - related party | 608,668 | 138,967 |
Net cash used in operating activities | (4,517,457) | (4,208,274) |
Cash flows from investing activities: | ||
Purchase of intangible assets | (30,000) | |
Proceeds from contribution of net assets of Slinger Bag Limited | 73,400 | |
Net cash (used in) provided by investing activities | (30,000) | 73,400 |
Cash flows from financing activities: | ||
Distribution to shareholder | (332,239) | |
Proceeds from notes payable - related party | 3,300,000 | 2,100,000 |
Proceeds from note payable | 3,120,000 | 500,000 |
Repayments of notes payable - related party | (1,000,000) | |
Proceeds from convertible note payable | 1,950,000 | |
Net cash provided by financing activities | 5,420,000 | 4,217,761 |
Effect of exchange rate fluctuations on cash and cash equivalents | (23,594) | (5,034) |
Increase in cash and cash equivalents | 848,949 | 77,853 |
Cash and cash equivalents at beginning of period | 79,847 | 1,994 |
Cash and cash equivalents at end of period | 928,796 | 79,847 |
Supplemental disclosure of cash flow information: | ||
Interest paid | 263,268 | 224,726 |
Income taxes paid | 3,668 | |
Supplemental disclosure of non-cash investing and financing activities: | ||
Forgiveness of net liabilities owed to former majority shareholder | 15,289 | |
Shares issuable related to convertible note payable agreement | 1,492,188 | |
Debt discount due to derivative liability | 673,809 | |
Conversion of note payable and accrued interest into common stock | 182,845 | |
Warrants issued with note payable | 112,990 | |
Net assets contributed from Slinger Bag Limited | (967,680) | |
Transfer of convertible note payable to note payable | 1,700,000 | |
Transfer of notes payable to notes payable - related party | 1,820,000 | |
Shares and warrants issued in connection with purchase of trademark | 85,583 | |
Conversion of notes payable and accrued interest into common stock | 1,937,041 | |
Warrants and shares issued with note payable | $ 158,331 |
Organization and Basis of Prese
Organization and Basis of Presentation | 12 Months Ended |
Apr. 30, 2021 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Organization and Basis of Presentation | NOTE 1: ORGANIZATION AND BASIS OF PRESENTATION Organization Lazex Inc. (“Lazex”) was incorporated under the laws of the State of Nevada on July 12, 2015. On August 23, 2019, the majority owner of Lazex entered into a Stock Purchase Agreement with Slinger Bag Americas Inc., a Delaware corporation (“Slinger Bag Americas”), which was 100% owned by Slinger Bag Ltd. (“SBL”), an Israeli company. In connection with the Stock Purchase Agreement, Slinger Bag Americas acquired 20,000,000 shares of common stock of Lazex for $332,239. On September 16, 2019, SBL transferred its ownership of Slinger Bag Americas to Lazex in exchange for the 20,000,000 shares of Lazex acquired on August 23, 2019. As a result of these transactions, Lazex owned 100% of Slinger Bag Americas and the sole shareholder of SBL owned 20,000,000 shares of common stock (approximately 82%) of Lazex. Effective September 13, 2019, Lazex changed its name to Slinger Bag Inc. On October 31, 2019, Slinger Bag Americas acquired control of Slinger Bag Canada, Inc., (“Slinger Bag Canada”) a Canadian company incorporated on November 3, 2017. There were no assets, liabilities or historical operational activity of Slinger Bag Canada. On February 10, 2020, Slinger Bag Americas became the 100% owner of SBL, along with SBL’s wholly owned subsidiary Slinger Bag International (UK) Limited (“Slinger Bag UK”), which was formed on April 3, 2019. The owner of SBL contributed it to Slinger Bag Americas for no consideration. The operations of Slinger Bag Inc., Slinger Bag Americas, Slinger Bag Canada, Slinger Bag UK and SBL are collectively referred to as the “Company.” The Company operates in the sporting and athletic goods business. The Company is the owner of the Slinger Launcher, which is a portable tennis ball launcher, as well as other associated tennis accessories. Effective February 25, 2020, the Company increased the number of authorized shares of common stock from 75,000,000 to 300,000,000 via a four-to-one forward split of its outstanding shares of common stock. All share and per share information contained in this report have been retroactively adjusted to reflect the impact of the stock split. Basis of Presentation The accompanying consolidated financial statements of the Company are presented in accordance with accounting principles generally accepted in the United States of America (“GAAP”). As a result of the transactions described above, the accompanying consolidated financial statements include the combined results of Slinger Bag Inc., Slinger Bag Americas, Slinger Bag Canada, Slinger Bag UK and SBL for the years ended April 30, 2021 and 2020. The contribution of the net assets of SBL is reflected as an equity contribution at historical cost on May 1, 2019, the beginning of the earliest period in which the entities were under common control. There was no historical activity in Slinger Bag Americas or Slinger Bag Canada prior to May 1, 2019. All intercompany accounts and transactions have been eliminated in consolidation. |
Going Concern
Going Concern | 12 Months Ended |
Apr. 30, 2021 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Going Concern | NOTE 2: GOING CONCERN The financial statements have been prepared on a going concern basis, which assumes the Company will be able to realize its assets and discharge its liabilities in the normal course of business for the foreseeable future. The Company has an accumulated deficit of $28,823,273 as of April 30, 2021, and more losses are anticipated in the development of the business. Accordingly, there is substantial doubt about the Company’s ability to continue as a going concern. These financial statements do not include any adjustments related to the recoverability and classification of assets or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern. The ability to continue as a going concern is dependent upon the Company generating profitable operations in the future and/or being able to obtain the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they become due. Management intends to finance operating costs over the next twelve months with existing cash on hand, loans from related parties, and/or private placement of debt and/or common stock. |
Summary of Significant Accounti
Summary of Significant Accounting Policies | 12 Months Ended |
Apr. 30, 2021 | |
Accounting Policies [Abstract] | |
Summary of Significant Accounting Policies | NOTE 3: SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Use of Estimates The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Accordingly, actual results could differ from those estimates. Financial Statement Reclassification Certain prior year amounts have been reclassified in these consolidated financial statements to conform to current year presentation. Cash and Cash Equivalents The Company considers all highly liquid investments with an original maturity of three months or less when purchased to be cash equivalents. The majority of payments due from banks for credit card transactions process within 24 to 48 hours and are accordingly classified as cash and cash equivalents. Accounts Receivable The Company’s accounts receivable are non-interest bearing trade receivables resulting from the sale of products and payable over terms ranging from 15 to 60 days. The Company provides an allowance for doubtful accounts at the point when collection is considered doubtful. Once all collection efforts have been exhausted, the Company charges-off the receivable with the allowance for doubtful accounts. The Company had no allowance for doubtful accounts as of April 30, 2021 or 2020. Inventory Inventory is valued at the lower of the cost (determined principally on a first-in, first-out basis) or net realizable value. The Company’s valuation of inventory includes inventory reserves for inventory that will be sold below cost and the impact of inventory shrink. Inventory reserves are based on historical information and assumptions about future demand and inventory shrink trends. The Company’s inventory as of April 30, 2021 consisted of $1,591,826 of finished goods, $1,777,028 of component and replacement parts, $347,362 of capitalized duty and freight, and a $23,000 inventory reserve. The Company’s inventory as of April 30, 2020 consisted of $663,750 of finished goods and $255,894 of component and replacement parts. Concentration of Credit Risk The Company maintains its cash in bank deposit accounts, the balances of which at times may exceed insured limits. The Company continually monitors its banking relationships and consequently has not experienced any losses in such accounts. While we may be exposed to credit risk, we consider the risk remote and do not expect that any such risk would result in a significant effect on our results of operations or financial condition. Revenue Recognition The Company recognizes revenue in accordance with Accounting Standards Codification (“ASC”) 606, the core principle of which is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled to receive in exchange for those goods or services. The Company recognizes revenue for its performance obligation associated with its contracts with customers at a point in time once products are shipped. Amounts collected from customers in advance of shipping products ordered are reflected as deferred revenue on the accompanying consolidated balance sheets. The Company’s standard terms are non-cancelable and do not provide for the right-of-return, other than for defective merchandise covered under the Company’s standard warranty. The Company has not historically experienced any significant returns or warranty issues. Fair Value of Financial Instruments Fair value of financial and non-financial assets and liabilities is defined as an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. The three-tier hierarchy for inputs used in measuring fair value, which prioritizes the inputs used in the methodologies of measuring fair value for assets and liabilities, is as follows: Level 1 — Quoted prices in active markets for identical assets or liabilities Level 2 — Observable inputs other than quoted prices in active markets for identical assets and liabilities Level 3 — Unobservable pricing inputs in the market Financial assets and financial liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurements. Our assessment of the significance of a particular input to the fair value measurements requires judgment and may affect the valuation of the assets and liabilities being measured and their categorization within the fair value hierarchy. The Company’s financial instruments consist of cash and cash equivalents, accounts receivable, and accounts payable. The carrying amount of these financial instruments approximates fair value due to their short-term maturity. The Company’s derivative liabilities were calculated using Level 2 assumptions on the issuance date via a Black-Scholes option pricing model whose assumptions are in line with the assumptions noted below in the warrant section. Income Taxes Income taxes are accounted for in accordance with the provisions of ASC 740, Accounting for Income Taxes. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amounts that are more likely than not to be realized. Intangible Asset Intangible asset relates to the “Slinger” technology trademark, which the Company purchased on November 10, 2020. The trademark is amortized over its expected life of 20 years. Amortization expense for the year ended April 30, 2021 and 2020 was $2,730 and zero, respectively. The amount of amortization expense for each of the next five years will be approximately $5,800 per year. Long-Lived Assets In accordance with ASC 360-10, the Company evaluates long-lived assets for impairment whenever events or changes in circumstances indicate that their net book value may not be recoverable. When such factors and circumstances exist, the Company compares the projected undiscounted future cash flows associated with the related asset or group of assets over their estimated useful lives against their respective carrying amount. If those net undiscounted cash flows do not exceed the carrying amount, impairment, if any, is based on the excess of the carrying amount over the fair value based on the market value or discounted expected cash flows of those assets and is recorded in the period in which the determination is made. There was no impairment of long-lived assets identified during the year ended April 30, 2021 or 2020. Share-Based Payment The Company accounts for share-based compensation in accordance with ASC 718, Compensation-Stock Compensation (ASC 718). Under the fair value recognition provisions of this topic, stock-based compensation cost is measured at the grant date based on the fair value of the award and is recognized as an expense on a straight-line basis over the requisite service period, which is the vesting period. Warrants The Company grants warrants to key employees and executives as compensation on a discretionary basis. The Company also grants warrants in connection with certain note payable agreements and other key arrangements. The Company is required to estimate the fair value of share-based awards on the measurement date and recognize as expense that value of the portion of the award that is ultimately expected to vest over the requisite service period. Warrants granted in connection with ongoing arrangements are more fully described in Note 7: Note Payable and Note 9: Shareholders’ Deficit. The warrants granted during the year ended April 30, 2021 and 2020 were valued using a Black-Scholes option pricing model on the date of grant using the following assumptions: 2021 2020 Expected life in years 2 – 10 years 2 -10 years Stock price volatility 148% - 280% 121% - 144% Risk free interest rate 0.12% - 1.64% 0.36% - 2.43% Expected dividends 0% 0% Foreign Currency Translation A portion of SBL’s operations are conducted in Israel and its functional currency is the Israeli Shekel, the Company’s operations of Slinger Bag Canada are conducted in its functional currency of Canadian Dollars, and the Company’s Slinger Bag UK operations are conducted in its functional currency of the British pound (GBP). The accounts of SBL, Slinger Bag Canada, and Slinger Bag UK have been translated into U.S. dollars (“USD”). Assets and liabilities are translated into USD at the applicable exchange rates at period-end. Shareholders’ equity is translated using historical exchange rates. Revenue and expenses are translated at the average exchange rates for the period. Any translation adjustments are included as foreign currency translation adjustments on the consolidated statements of operations and comprehensive loss. Earnings Per Share Basic earnings per share are calculated by dividing income available to shareholders by the weighted-average number of common shares outstanding during each period. Diluted earnings per share are computed using the weighted average number of common and dilutive common share equivalents outstanding during the period. The Company had 6,921,299 and 8,137,859 common shares issuable as of April 30, 2021 and 2020, respectively, (see Note 5 and 6) which were not included in the calculation of diluted earnings per share as the effect is antidilutive. The Company also had outstanding notes payable convertible into zero and 7,465,811 shares of common stock as of April 30, 2021 and 2020, respectively, (see Note 6), outstanding warrants exercisable into 24,503,107 and 13,000,000 shares of common stock as of April 30, 2021 and 2020, respectively, and 21,786 and zero shares related to make-whole provisions as of April 30, 2021 and 2020, respectively, (see Note 7), which were excluded from the calculation of diluted earnings per share as the effect is antidilutive. As a result, the basic and diluted earnings per share are the same for each of the periods presented. Recent Accounting Pronouncements In December 2019, the FASB issued Accounting Standards Update (ASU), 2019-12, Simplifying the Accounting for Income Taxes Income Taxes Other recently issued accounting pronouncements did not, or are not believed by management to, have a material effect on the Company’s present or future consolidated financial statements. |
Intangible Asset
Intangible Asset | 12 Months Ended |
Apr. 30, 2021 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Intangible Asset | NOTE 4: INTANGIBLE ASSET On November 10, 2020, the Company entered into a Trademark Assignment Agreement to acquire the “Slinger” trademark for $30,000 in cash, 35,000 shares of the Company’s common stock, and warrants to purchase 50,000 shares of the Company’s common stock at an exercise price of $0.50 per share. The warrants vested immediately and have a contractual life of 10 years. The common stock was valued at the closing stock price on November 10, 2020 and the warrants were valued using a Black-Scholes option pricing model, for a fair value of $35,351 and $50,232, respectively. The purchase price of the trademark was determined to be $115,583. |
Note Payable - Related Party
Note Payable - Related Party | 12 Months Ended |
Apr. 30, 2021 | |
Debt Disclosure [Abstract] | |
Note Payable - Related Party | NOTE 5: NOTE PAYABLE – RELATED PARTY On October 1, 2019, the Company entered into a loan agreement with a related party entity controlled by the former shareholder of Slinger Bag Canada for borrowings of $500,000 bearing interest at 12% per annum. All principal and accrued interest were due on demand under the original agreement. On December 13, 2019, the Company entered into an Amended and Restated Loan Agreement making all principal and accrued interest due on July 15, 2020, which was later amended to extend the due date to September 1, 2021. On December 3, 2019, the Company entered into a loan agreement with the same related party for borrowings of $500,000 bearing interest at 12% per annum. All principal and accrued interest were due on demand under the original agreement. On December 13, 2019, the Company entered into an Amended and Restated Loan Agreement increasing the interest rate earned from 12% to 24% per annum and making all principal and accrued interest due on July 15, 2020, which was later amended to extend the due date to September 1, 2021. On December 11, 2019, the Company entered into a loan agreement with the same related party for borrowings of $700,000 bearing interest at 24% per annum. All principal and accrued interest were due on July 15, 2020. On July 8, 2020, the terms of the debt were amended to extend the due date to January 8, 2021, which was later amended to extend the due date to September 1, 2021. On January 6, 2020, the Company entered into a loan agreement with the same related party for borrowings of $200,000 bearing interest at 24% per annum. All principal and accrued interest were due on January 8, 2021, which was later amended to extend the due date to September 1, 2021. On February 28, 2020, the Company entered into a loan agreement with the same related party for borrowings of $200,000 bearing interest at 24% per annum. All principal and accrued interest were due on February 28, 2021, which was later amended to extend the due date to September 1, 2021. On May 12, 2020 and July 3, 2020, the Company entered into loan agreements with the same related party for borrowings of $1,000,000 and $500,000, respectively, bearing interest at 24% per annum. All principal and accrued interest were due on August 31, 2020 and July 3, 2021, respectively, which was later amended to extend the due date to September 1, 2021. On July 8, 2020, the Company entered into a Purchase Order Financing Agreement (“PO Financing Agreement”) whereby $1,900,000 of the total $3,600,000 in outstanding debt due to the related party as of the date of the agreement was labeled as inventory financing (“PO Financing Amount”). The PO Financing Amount, along with any accrued interest, is due in full no later than six months from the effective date of the PO Financing Agreement, which was later amended to extend the due date to September 1, 2021. The outstanding balance of the PO Financing Agreement bears interest at a rate of 2% per month. The Company agreed to repay the PO Financing Amount together with any accrued, but unpaid, interest thereon out of proceeds from the sale of its products, licensing activities, revenue to be generated from operations and/or amounts received by the Company from investors, lenders, financiers, financing sources or other persons before making payments of any other nature (including dividends and distributions), except for payments required to finance the Company’s operations. On August 10, 2020, the Company entered into a loan agreement with the same related party for borrowings of $250,000 under the PO Financing Agreement bearing interest at 24% per annum. All principal and accrued interest were due on August 10, 2021, which was later amended to extend the due date to September 1, 2021. On September 7, 2020, the outstanding debt from the existing related party lender was amended to reduce the interest rate to 9.5% per annum on all outstanding loans, including the PO Financing Agreement, effective the date of the agreement. As consideration for agreeing to reduce the interest rate, the Company issued the related party warrants to purchase 2,500,000 shares of the Company’s common stock at an exercise of $0.001 per share. The warrants vested immediately and have a contractual life of 10 years. The amendment of the outstanding debt was treated as an extinguishment of the debt and therefore the value of the warrants issued to the lender of $1,999,487 was expensed as a loss on extinguishment of debt during the year ended April 30, 2021. On September 8, 2020, the related party lender agreed to extend the due date of all outstanding loans to September 1, 2021. On September 15, 2020, the Company entered into a loan agreement with the same related party for borrowings of $250,000 bearing interest at 9.5% per annum and due in full on September 15, 2021. In connection with the loan, the Company issued warrants to the related party lender to purchase 125,000 shares of the Company’s common stock at an exercise price of $0.001 per share. The warrants vested immediately and have a contractual life of 10 years. The note was discounted by $70,130 allocated from the valuation of the warrants issued. The discount recorded on the note is being amortized through the maturity date, which amounted to $43,615 and zero for the years ended April 30, 2021 and 2020, respectively, and is recorded in amortization of debt discount on the statement of operations. As of April 30, 2021, the remaining discount was $26,515. On November 24, 2020, the Company entered into a loan agreement with the same related party for borrowings of $300,000 bearing interest at 9.5% per annum and due in full on November 24, 2021. In connection with the loan, the Company issued warrants to the related party lender to purchase 125,000 shares of the Company’s common stock at an exercise price of $0.001 per share. The warrants vested immediately and have a contractual life of 10 years. This note was discounted by $88,201 allocated from the valuation of the warrants issued. The discount recorded on the note is being amortized through the maturity date, which amounted to $37,939 and zero for the years ended April 30, 2021 and 2020, respectively, and is recorded in amortization of debt discount on the statement of operations. As of April 30, 2021, the remaining discount was $50,262. On December 3, 2020, Mont-Saic Investments LLC (“Mont-Saic”) entered into an Assignment and Conveyance Agreement with 2490585 Ontario Inc., the Company’s existing related party lender. In connection with the agreement, Mont-Saic sold its full right, title and interest in its outstanding notes payable amounting to $1,820,000, which consisted of a $1,700,000 note payable (see Note 6) and a $120,000 note payable (see Note 7), to 2490585 Ontario Inc., along with the 1,216,560 shares of common stock previously issued to Mont-Saic in connection with the debt agreement and the rights to receive the remaining 6,921,299 shares issuable. Subsequent to this point in time, the outstanding debt of $1,820,000 and all accrued interest is payable to 2490585 Ontario Inc., and future interest will accrue at a rate of 9.5% per annum consistent with the rate being charged on their other outstanding debt. The scheduled maturity date of the debt remains unchanged and is due June 1, 2021. As of April 30, 2021, there remain 6,921,299 shares issuable related to this note. Total outstanding borrowings from this related party as of April 30, 2021 and 2020 amounted to $6,220,000 and $2,100,000, respectively. The outstanding amount is net of total discounts of $76,777 for a net book value of $6,143,223 as of April 30, 2021. Interest expense related to this related party for the year ended April 30, 2021 and 2020 amounted to $608,668 and $171,918, respectively. Accrued interest due to the related party amounted to $747,636 and $138,967 as of April 30, 2021 and 2020, respectively. On March 25, 2021, the Company entered into a loan agreement with a different related party for borrowings of $1,000,000 bearing interest at 1% per annum and due in full on April 25, 2021. The Company repaid the loan in full at maturity and there were no outstanding borrowings as of April 30, 2021. |
Convertible Notes Payable
Convertible Notes Payable | 12 Months Ended |
Apr. 30, 2021 | |
Debt Disclosure [Abstract] | |
Convertible Notes Payable | NOTE 6: CONVERTIBLE NOTES PAYABLE On June 1, 2019, the Company entered into a convertible note payable agreement with Mont-Saic Investments LLC (“Mont-Saic”) which provided for borrowings of $1,700,000 bearing interest at a rate of 12.6% per annum. All outstanding amounts were due on the maturity date 360 days after the loan issue date. The Company may repay up to 50% of the outstanding balance on the loan prior to the maturity date at their discretion. The outstanding principal and accrued interest are convertible into shares of the Company’s common stock at any time at the option of the debtholder at a conversion price equal to 75% of the lowest closing price of the common stock as defined in the agreement. The convertible note payable agreement, as amended on September 11, 2019, also provided Mont-Saic with a warrant giving them the right to acquire 33% of the outstanding shares of SBL on a fully-diluted basis for no consideration up through one year after the maturity date. On September 16, 2019, Mont-Saic and Slinger Bag Inc. entered into a warrant assignment and conveyance agreement which updated Mont-Saic’s right to acquire 33% of the outstanding common stock shares of SBL to Slinger Bag Inc. The allocated value of the warrant of $1,492,188 was recorded as a discount to the outstanding note balance. On May 6, 2020, the Company issued 1,216,560 shares of common stock as partial satisfaction of the shares issuable. On June 1, 2020, the Company and Mont-Saic entered into an amendment to the convertible note payable agreement to eliminate the conversion right contained in the original agreement and extend the maturity date to June 1, 2021. The Company evaluated the conversion option under the guidance in ASC 815-10, Derivatives and Hedging, and determined it to have characteristics of a derivative liability. Under this guidance, this derivative liability is marked-to-market at each reporting period with the non-cash gain or loss recorded in the period as a gain or loss on derivatives. The value of the conversion option derivative amounted to $566,667 as of the issuance date on September 11, 2019, which was recorded as a discount to the outstanding note balance less $358,855 representing the amount of the conversion option exceeding the face value of the note payable which was recorded immediately as interest expense, and a derivative liability. On June 1, 2020, in connection with the elimination of the conversion option, this derivative ceased to exist and the value of the derivate of $566,667 was recognized as a loss on extinguishment of debt on the consolidated statements of operations for the year ended April 30, 2021. The combined discount relating to the warrant and conversion option were amortized over the term of the agreement. Amortization of debt discounts during the year ended April 30, 2020 amounted to $1,493,939, and were recorded as amortization of debt discount in the accompanying consolidated statements of operations. The remaining $206,061 was amortized during the year ended April 30, 2021. On December 3, 2020, Mont-Saic entered into an Assignment and Conveyance Agreement with the Company’s exiting related party lender wherein Mont-Saic sold its full right, title and interest in its outstanding notes payable amounting to $1,820,000, which consisted of the $1,700,000 note payable and the $120,000 note payable (see Note 7), to the Company’s related party lender, along with the 1,216,560 shares of common stock previously issued to Mont-Saic in connection with the debt agreement and the rights to receive the remaining 6,921,299 shares issuable (see Note 5). On November 20, 2019, the Company entered into a convertible note payable agreement for borrowings of $125,000 bearing interest at 12% per annum. All outstanding borrowings and accrued interest were due on November 20, 2020. The outstanding principal and accrued interest are convertible into shares of the Company’s common stock at any time at the option of the debtholder at a conversion price equal to 70% of the lowest closing price of the common stock as defined in the agreement. On March 2, 2020, the holder elected to convert the outstanding principal of $125,000 and accrued interest of $4,274 into 369,354 shares of the Company’s common stock in accordance with the terms in the agreement. The Company evaluated the conversion option under the guidance in ASC 815-10, Derivatives and Hedging, and determined it to have characteristics of a derivative liability. Under this guidance, this derivative liability is marked-to-market at each reporting period with the non-cash gain or loss recorded in the period as a gain or loss on derivatives. The value of the conversion option derivative amounted to $53,571 as of the issuance date on November 20, 2019, which was initially recorded as a discount to the outstanding note balance and a derivative liability. The discount of $53,571 was fully amortized during the year ended April 30, 2020 upon the conversion of the outstanding note payable balance. Upon conversion of the note payable balance, the derivative liability amount of $53,571 was reclassified as additional paid-in capital as part of shareholders’ equity. On February 11, 2020, the Company entered into a convertible note payable agreement for borrowings of $125,000 bearing interest at 12% per annum. All outstanding borrowings and accrued interest are due on February 11, 2021. The outstanding principal and accrued interest are convertible into shares of the Company’s common stock at any time at the option of the debtholder at a conversion price equal to 70% of the lowest closing price of the common stock as defined in the agreement. The Company evaluated the conversion option under the guidance in ASC 815-10, Derivatives and Hedging, and determined it to have characteristics of a derivative liability. Under this guidance, this derivative liability is marked-to-market at each reporting period with the non-cash gain or loss recorded in the period as a gain or loss on derivatives. The value of the conversion option amounted to $53,571 as of the issuance date on February 11, 2020, which was initially recorded as a discount to the outstanding note balance and a derivative liability. The discount was being amortized over the term of the agreement. On September 4, 2020, the Company and the convertible debt holder entered into an agreement to convert the outstanding convertible note payable balance of $125,000 and accrued interest of $8,466 into 300,000 shares of the Company’s common stock. Under the guidance in ASC 470-20-40-16, the Company recognized an expense at the conversion date equal to the fair value of the shares transferred after the change in terms, less the fair value of securities issuable under the original conversion terms. The excess in value, which amounted to $51,412 was recorded as an induced conversion loss in the consolidated statements of operations during the year ended April 30, 2021. At the time of the conversion, the remaining debt discount was fully amortized and the derivative liability amount of $53,571 was reclassified as additional paid-in capital as part of shareholders’ equity. Amortization of debt discounts during the year ended April 30, 2021 and 2020 was $42,872 and $10,699, respectively, and was recorded as amortization of debt discount in the accompanying consolidated statements of operations. The unamortized discount balance amounted to zero and $42,872 as of April 30, 2021 and 2020, respectively. Total outstanding principal of convertible notes payable at April 30, 2021 and 2020 amounted to zero and $1,825,000, respectively. The outstanding balances are netted with debt discounts at April 30, 2021 and 2020 of zero and $248,933, respectively. |
Note Payable
Note Payable | 12 Months Ended |
Apr. 30, 2021 | |
Debt Disclosure [Abstract] | |
Note Payable | NOTE 7: NOTE PAYABLE On March 16, 2020, the Company entered into a promissory note payable whereby the Company borrowed $500,000 bearing interest at 12% per annum. Interest on the note is payable monthly and outstanding principal on the note is due in full on March 16, 2022. In connection with the promissory note payable on March 16, 2020, the Company issued warrants to purchase 500,000 shares of the Company’s common stock at an exercise price equal to a 40% discount of the market price of the Company’s stock, as defined in the agreement. The warrants expire on March 16, 2022 and are fully vested upon issuance. The note was discounted by $112,990 based on an allocation of the value of the warrants issued. The discount recorded on the note was amortized into amortization of debt discount through the maturity date, which amounted to $35,542 and $6,965 for years ended April 30, 2021 and 2020, respectively. On December 15, 2020, the debt holder agreed to convert the outstanding note payable of $500,000 into 500,000 shares of the Company’s common stock as full settlement of the promissory note payable. Accrued interest on the note was paid in cash. As a result of this settlement, the Company recognized the unamortized debt discount of $70,483 as a loss on extinguishment of debt on the consolidated statements of operations during the year ended April 30, 2021. On June 30, 2020, the Company entered into a loan agreement with Mont-Saic to borrow $120,000. This loan bears interest at an annual rate of 12.6% and is required to be repaid in full, together with all accrued, but unpaid, interest by June 30, 2021. On December 3, 2020, Mont-Saic entered into an Assignment and Conveyance Agreement with the Company’s exiting related party lender wherein Mont-Saic sold its full right, title and interest in this note to the Company’s related party lender (see Note 5). On December 24, 2020, the Company entered into a promissory note with a third-party to borrow $1,000,000. The promissory note bore interest at 2.25% and was due February 8, 2021. On February 2, 2021, the Company and the third-party entered into an amendment to extend the promissory note to April 30, 2021. On April 11, 2021, the Company and the lender entered into an agreement whereby the lender converted the promissory note into 272,332 shares of Company stock, which were issued to the lender at a 20% discount from the closing price of the stock on the day prior to the conversion. In addition to the discount, the agreement contains a guarantee that the aggregate gross sales of the shares by the lender will be no less than $1,500,000 over the next three years and if the aggregate gross sales are less than $1,500,000 the Company will issue additional shares of common stock to the lender for the difference between the total gross proceeds and $1,500,000, which could result in an infinite number of shares being required to be issued. The Company evaluated the conversion option of the note payable to shares under the guidance in ASC 815-40, Derivatives and Hedging, and determined the conversion option qualified for equity classification. The Company also evaluated the profit guarantee under ASC 815, Derivatives and Hedging, and determined it to be a make-whole provision, which is an embedded derivative within the host instrument. As the economic characteristics are dissimilar to the host instrument, the profit guarantee was bifurcated from the host instrument and stated as a separate derivative liability, which is marked to market at the end of each reporting period with the non-cash gain or loss recorded in the period as a gain or loss on derivative. On the date of conversion, the Company recognized a $1,501,914 loss on extinguishment of debt, which represented the difference between the promissory note and the fair value of the shares issued of $1,250,004, which were recorded in shareholders’ equity, as well as the derivative liability of $1,251,910, which was valued using a . The fair value of the derivative liability was $1,229,851 as of April 30, 2021, and the Company recognized a gain on change in fair value of $22,059 for the year ended April 30, 2021. On April 15, 2021, the Company entered into a $2,000,000 note payable (the “Note”). The Note matures April 14, 2023 and bears interest at fifteen percent (15%) per year. The Company pays interest at maturity, at which time all principal and unpaid interest is due. The Note is collateralized by all business assets, including patents, trademarks and other intellectual property. It is also collateralized by the ownership of Slinger Bag Americas, Inc., Slinger Bag Canada, Inc., Slinger Bag Limited, and Slinger Bag International (UK) Limited. In connection with the Note, the Company issued 2,200,000 warrants with an exercise price of $0.25. The exercise price has customary anti-dilution protection for stock splits, mergers, etc. Additionally, the warrant contains a stipulation that the Company will guarantee the value of the shares sold will be no less, on average, than $1.50 per share through April 15, 2023. If the value is less than $1.50, the Company will issue additional shares of common stock to compensate for the shortfall, which could result in an infinite number of shares being required to be issued. The Company evaluated the warrants and the profit guarantee under the guidance in ASC 815-40, Derivatives and Hedging, and determined they represent a derivative liability given the profit guarantee represents a make-whole provision that is not separated from the host instrument. The derivative liability is marked to market at the end of each reporting period with the non-cash gain or loss recorded in the period as a gain or loss on derivative. The fair value of the derivative liability on the date of the execution of the Note was valued using a at Amortization of debt discounts during the year ended April 30, 2021 was $10,477, which was recorded as amortization of debt discount in the accompanying consolidated statements of operations. The unamortized discount balance amounted to $1,989,523 as of April 30, 2021. The fair value of the derivative liability was $12,583,598 as of April 30, 2021, and the Company recognized a gain on change in fair value of $1,917,580 for the year ended April 30, 2021. |
Related Party Transactions
Related Party Transactions | 12 Months Ended |
Apr. 30, 2021 | |
Related Party Transactions [Abstract] | |
Related Party Transactions | NOTE 8: RELATED PARTY TRANSACTIONS In support of the Company’s efforts and cash requirements, it may rely on advances from related parties until such time that the Company can support its operations or attain adequate financing through sales of its equity or traditional debt financing. There is no formal written commitment for continued support by officers, directors, or shareholders. Amounts represent advances, amounts paid in satisfaction of liabilities, or accrued compensation that has been deferred. The advances are considered temporary in nature and have not been formalized by a promissory note. As of April 30, 2021 and 2020, amounts due to related parties were $1,283,464 and $377,106, respectively, which represented unpaid salaries and bonuses and reimbursable expenses due to officers of the Company. The Company has outstanding notes payable of $6,220,000 and $2,100,000 and accrued interest of $747,636 and $138,967 due to a related party as of April 30, 2021 and 2020, respectively (see Note 5). The Company recognized net sales of $615,584 during the year ended April 30, 2021, to a related party. As of April 30, 2021, the related party had accounts receivable due to the Company of $86,956. There were no sales to this related party during the year ended April 30, 2020. |
Stockholders' Deficit
Stockholders' Deficit | 12 Months Ended |
Apr. 30, 2021 | |
Stockholders' Equity Note [Abstract] | |
Stockholders' Deficit | NOTE 9: SHAREHOLDERS’ DEFICIT Common Stock The Company has 300,000,000 shares of common stock authorized with a par value of $0.001 per share. As of April 30, 2021 and 2020, the Company had 27,642,828 and 24,749,354 shares of common stock issued and outstanding, respectively. Equity Transactions During Year Ended April 30, 2020 On March 2, 2020, the Company issued 369,354 shares of common stock for the conversion of an outstanding convertible note payable of $125,000 and accrued interest of $4,274. Upon conversion of the note payable balance, the derivative liability of $53,571 related to the convertible note payable was reclassified as additional paid-in capital as part of shareholders’ equity. The purchase price of $332,239 under the Stock Purchase Agreement (see Note 1), which resulted in shares of Lazex being acquired by the shareholder of SBL, was paid by SBL on behalf of the shareholder. The amount has been recorded as a distribution to shareholder and therefore is classified as a reduction of additional paid-in capital. In connection with the Stock Purchase Agreement (see Note 1), net liabilities of $15,289 were forgiven by the previous majority shareholder of the Company, which was recorded as an increase to additional paid-in capital. On March 16, 2020, the Company issued warrants valued at $112,990 in connection with a note payable (see Note 7), which increased additional paid-in capital. Equity Transactions During Year Ended April 30, 2021 On May 6, 2020, the Company issued 1,216,560 shares of its common stock to Mont-Saic as partial satisfaction of the shares issuable under a convertible note payable agreement. On May 15, 2020, the Company issued 243,800 shares of its common stock to a vendor as compensation for business advisory services performed, which resulted in $65,826 of general and administrative expenses for the year ended April 30, 2021. On September 4, 2020, the Company issued 300,000 shares of its common stock for the conversion of a convertible note payable (see Note 6). The fair value of the common stock was $238,449. On October 8, 2020, the Company issued 100,000 shares of its common stock to a vendor as compensation for business advisory services performed, which resulted in $114,000 of operating expenses for the year ended April 30, 2021. On October 28, 2020, the Company granted 400,000 warrants to a service provider for advertising services over the next year. The warrants have an exercise price of $0.75 per share, a contractual life of 10 years from the date of issuance, and vest quarterly over a year from the grant date. The warrants were valued using a Black-Scholes option pricing model and the expense related to the issuance of the warrants is being recognized over the service agreement. The Company recognized $221,826 of operating expenses related to this agreement during the year ended April 30, 2021. On October 29, 2020, the Company and the three members of its advisory board entered into agreements whereby each member will receive an aggregate number of warrants each quarter equal to $7,500 divided by the average closing price of the Company’s stock for the five days prior to the Company’s most recently completed fiscal quarter. The warrants vest quarterly, have an exercise price of $0.001 per share and a contractual life of 10 years from the date of issuance. 43,107 warrants were issued under these agreements during the year ended April 30, 2021. The warrants were valued using a Black-Scholes option pricing model, which resulted in operating expenses of $48,502 during the year ended April 30, 2021. On November 24, 2020 and on January 11, 2021, the Company issued 46,087 and 100,000 shares of its common stock, respectively, to two vendors as compensation for marketing and other advisory services. The Company also issued 55,945 shares of its common stock on November 24, 2020 to a third-party vendor as full settlement of payables of $30,000 related to consulting services, which resulted in a $25,278 loss on extinguishment of debt. The total fair value of the shares issued related to these transactions was $198,386, of which $39,750 was recognized in prepaids and other assets and will be recognized over the period that the related services are rendered. As of April 30, 2021, there was $26,500 in prepaids related to these transactions and the remaining $146,608 was recognized as operating expenses for the year ended April 30, 2021. On November 10, 2020, the Company issued 35,000 shares of common stock as partial payment for the purchase of the Slinger trademark. The common stock had a fair value of $35,351 on the date of issuance, which has been capitalized as an intangible asset on the balance sheet. On December 15, 2020, the Company issued 500,000 shares of common stock as full payment of its $500,000 note payable to a third party (see Note 7). The fair value of the shares issued was $500,000. On April 11, 2021, the Company issued 272,332 shares of its common stock for the conversion of a note payable (see Note 7). The fair value of the shares issued was $1,250,004. On April 11, 2021 and on April 13, 2021, the Company issued 18,750 and 5,000 shares of its common stock to two vendors as compensation for marketing and advisory services, which resulted in an operating expense of $43,294 for the year ended April 30, 2021. During the three months ended April 30, 2021, the Company granted an aggregate total of 60,000 warrants and equity options for 120,00 shares (which have all expired unexercised) to four of its brand ambassadors as compensation. The warrants have an exercise price of $0.001 per share, a contractual life of 10 years from the date of issuance and are vested immediately upon grant and the shares had a 90 day exercise period at a 50% discount on the stock price. The warrants and shares were valued using a Black-Scholes option pricing model and the expense related to the issuance of the warrants and equity options is being recognized over the service agreements. The Company recognized $59,838 and $98,457 of operating expenses related to the warrant and equity options, respectively, during the year ended April 30, 2021. Common Stock Issuable As discussed in Note 6, on September 16, 2019, the Company entered into a warrant assignment and conveyance agreement with Mont-Saic, pursuant to which the Company allows Mont-Saic to acquire 33% of the outstanding common stock shares of the Company on a fully-diluted basis for no consideration. The allocated value of the warrant amounted to $1,492,188 was reflected as additional paid-in capital during the year ended April 30, 2020. There were 8,137,859 shares of common stock that were issuable under this agreement and as of April 30, 2020 none of the shares had been issued. As of April 30, 2021, 1,216,560 shares have been issued and the remaining 6,921,299 continue to be issuable to a related party. Warrants Issued for Compensation On April 30, 2020, the Company granted an aggregate total of 12,500,000 warrants to key employees and officers of the Company as compensation. The warrants have an exercise price of $0.001 per share, a contractual life of 10 years from the date of issuance and are vested immediately upon grant. The warrants granted as compensation during the year ended April 30, 2020 were valued using a Black-Scholes option pricing model. The total share-based compensation expense related to the issuance of the warrants amounted to $3,741,746. On February 9, 2021, the Company issued 6,000,000 warrants to key employees and officers of the Company as a performance bonus. The warrants have an exercise price of $0.001 per share for non-U.S. warrant holders (1,500,000 warrants) and an exercise price of $3.94, which is equal to the closing price of the Company’s common stock on the grant date, for U.S. warrant holders. The warrants were valued using a Monte Carlo simulation with the key inputs as of 4/30/20 being the executives’ three-year agreement term, the Company’s $100 million market capitalization threshold being achieved, a risk free rate of 0.76%, and a stock price volatility of 63% because the warrant grant was contingent on a market condition being achieved. The Company recognized $70,997 of share-based compensation related to these awards during the year ended April 30, 2021. |
Commitments and Contingencies
Commitments and Contingencies | 12 Months Ended |
Apr. 30, 2021 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | NOTE 10: COMMITMENTS AND CONTINGENCIES Leases The Company leases office space under short-term leases with terms under a year. Total rent expense for the year ended April 30, 2021 and 2020 amounted to $8,400 and $2,800, respectively. Contingencies From time to time, the Company may become involved in legal proceedings arising in the ordinary course of business. The Company is not presently a party to any legal proceedings that it currently believes would individually or taken together have a material adverse effect on the Company’s business or financial statements. |
Income Taxes
Income Taxes | 12 Months Ended |
Apr. 30, 2021 | |
Income Tax Disclosure [Abstract] | |
Income Taxes | NOTE 11: INCOME TAXES The Company does business in the US through its subsidiaries Slinger Bag Inc. and Slinger Bag Americas. It also does business in Israel through SBL whose operations are reflected in the Company’s consolidated financial statements. The Company’s operations in Canada and the UK were immaterial for the years ended April 30, 2021 and 2020. Net deferred tax assets from operations in the US, using an effective tax rate of 21%, consisted of the following: April 30, April 30, 2021 2020 Deferred tax assets: Loss carryforwards $ 788,400 $ 301,000 Accrued payroll 333,700 - Related party accruals 194,400 79,000 Start-up costs 109,600 61,000 Other 17,900 - Valuation allowance (1,444,000 ) (441,000 ) Net deferred tax assets $ - $ - The income tax provision differs from the amount of income tax determined by applying the applicable statutory income tax rate to pretax loss due to the following for the years ended April 30, 2021 and 2020: April 30, April 30, 2021 2020 Income tax benefit based on book loss at US statutory rate $ (3,832,300 ) $ (1,273,000 ) Share-based compensation and shares for services 188,100 786,000 Debt discount amortization 79,100 15,000 Related party accruals 127,800 79,000 Start-up costs - 61,000 Interest expense 2,630,000 41,000 Meals and entertainment - 1,000 Loss on extinguishment of debt 636,400 - Accrued payroll 215,400 - Gain on change in fair value of derivatives (407,300) - Other 1,500 - Valuation allowance 361,300 290,000 Total income tax provision $ - $ - The Company had net operating loss carryforwards of $3,032,000 and $1,424,000 as of April 30, 2021 and 2020, respectively, which can be used to offset future taxable income in the US for the years ended 2022 through 2041. Tax years that remain subject to examination are 2017 and forward. Net deferred tax assets from operations in Israel, using an effective tax rate of 23%, consisted of the following: April 30, April 30, 2021 2020 Deferred tax assets: Loss carryforwards $ 178,000 $ 384,000 Accrued expenses - 63,000 Start-up costs 13,000 - Research and development costs 113,000 23,000 Valuation allowance (304,000 ) (470,000 ) Net deferred tax assets $ - $ - The income tax provision differs from the amount of income tax determined by applying the applicable Israeli statutory income tax rate of 23% due to the following for the years ended April 30, 2021 and 2020: April 30, April 30, 2021 2020 Income tax provision (benefit) based on book income (loss) at Israeli statutory rate $ 80,000 $ (728,000 ) Debt discount amortization - 430,000 Related party accruals - 44,000 Travel expenses - 38,000 Research and development costs 113,000 23,000 Other non-deductible items - 9,000 Start-up costs 13,000 - Valuation allowance - 184,000 Loss carryforward (206,000 ) - Total income tax provision $ - $ - The Company had net operating loss carryforwards of approximately $774,000 and $1,671,000 as of April 30, 2021 and 2020, respectively, which can be used to offset future taxable income in Israel. All of the Company’s tax years since inception are open for examination. The Company’s policy is to record interest and penalties on uncertain tax positions as income tax expense. There were no interest or penalties recognized in the accompanying consolidated statements of operations for the year ended April 30, 2021 or 2020. |
Subsequent Events
Subsequent Events | 12 Months Ended |
Apr. 30, 2021 | |
Subsequent Events [Abstract] | |
Subsequent Events | NOTE 12: SUBSEQUENT EVENTS On May 26, 2021, the Company and the related party lender entered into a note conversion agreement whereby the related party lender agreed to convert its total outstanding borrowings as of that date of $6,220,000 into 1,636,843 shares of the Company’s common stock. Per the terms of the note conversion agreement the accrued interest related to the debt was not converted into shares and is still due to the related party. The note conversion agreement contains a guarantee that the aggregate gross sales of the shares by the related party will be no less than $6,220,000 over the next three years and if the aggregate gross sales are less than $6,220,000 the Company will issue additional shares of common stock to the related party for the difference between the total gross proceeds and $6,220,000. On June 21, 2021, the Company entered into a membership interest purchase agreement (“MIPA”) with Charles Ruddy (the “Seller”) to acquire a 100% ownership stake in Foundation Sports Systems, LLC (“Foundation Sports”) in exchange for 1,000,000 shares of common stock of the Company to be issued to the Seller and two other Foundation Sports employees in three tranches (the “Purchase Price”): (i) 600,000 shares of common stock on the closing date, 200,000 shares of common stock on the first anniversary of the closing date and (iii) 200,000 shares of common stock on the second anniversary of the closing date (collectively, the “Shares”), provided that 10% of the Shares of each tranche will be held back by the Company and not delivered to the recipients for a period of 12 months from the date of their issuance. The Shares are subject to a 12-month lock-up from their date of delivery during which time they may not be offered or sold by the Seller or any other recipient thereof without the express written consent of the Company. On June 23, 2021, the Company issued 540,000 shares of its common stock to the receipts under the MIPA, which consisted of 600,000 shares less a hold-back of 10% (i.e., 60,000 shares). On July 21, 2021, the Company entered into a Convertible Loan Agreement with PlaySight Interactive Ltd (the Borrower) wherein the Company granted the Borrower a $2,000,000 line of credit with a six-month maturity date. Any borrowings under the line of credit bear interest at a rate of 15% per annum. On July 26, 2021, the Company issued $300,000 to the Borrower under the line of credit. On July 23, 2021, the Company entered into a loan agreement with its related party lender for borrowings of $500,000. The loan is to be repaid within 30 days of receipt and shall bear interest at a rate of 12% per annum. On August 2, 2021, the Company entered into a loan agreement with its related party lender for borrowings of $500,000. The loan is to be repaid within 30 days of receipt and shall bear interest at a rate of 12% per annum. During the three months ended July 31, 2021, the Company issued 68,965 shares of its common stock to one vendor and two employees as compensation for marketing and other services rendered. During the three months ended July 31, 2021, the Company granted an aggregate total of 90,937 shares of its common stock to six brand ambassadors as compensation for services. |
Summary of Significant Accoun_2
Summary of Significant Accounting Policies (Policies) | 12 Months Ended |
Apr. 30, 2021 | |
Accounting Policies [Abstract] | |
Use of Estimates | Use of Estimates The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Accordingly, actual results could differ from those estimates. |
Financial Statement Reclassification | Financial Statement Reclassification Certain prior year amounts have been reclassified in these consolidated financial statements to conform to current year presentation. |
Cash and Cash Equivalents | Cash and Cash Equivalents The Company considers all highly liquid investments with an original maturity of three months or less when purchased to be cash equivalents. The majority of payments due from banks for credit card transactions process within 24 to 48 hours and are accordingly classified as cash and cash equivalents. |
Accounts Receivable | Accounts Receivable The Company’s accounts receivable are non-interest bearing trade receivables resulting from the sale of products and payable over terms ranging from 15 to 60 days. The Company provides an allowance for doubtful accounts at the point when collection is considered doubtful. Once all collection efforts have been exhausted, the Company charges-off the receivable with the allowance for doubtful accounts. The Company had no allowance for doubtful accounts as of April 30, 2021 or 2020. |
Inventory | Inventory Inventory is valued at the lower of the cost (determined principally on a first-in, first-out basis) or net realizable value. The Company’s valuation of inventory includes inventory reserves for inventory that will be sold below cost and the impact of inventory shrink. Inventory reserves are based on historical information and assumptions about future demand and inventory shrink trends. The Company’s inventory as of April 30, 2021 consisted of $1,591,826 of finished goods, $1,777,028 of component and replacement parts, $347,362 of capitalized duty and freight, and a $23,000 inventory reserve. The Company’s inventory as of April 30, 2020 consisted of $663,750 of finished goods and $255,894 of component and replacement parts. |
Concentration of Credit Risk | Concentration of Credit Risk The Company maintains its cash in bank deposit accounts, the balances of which at times may exceed insured limits. The Company continually monitors its banking relationships and consequently has not experienced any losses in such accounts. While we may be exposed to credit risk, we consider the risk remote and do not expect that any such risk would result in a significant effect on our results of operations or financial condition. |
Revenue Recognition | Revenue Recognition The Company recognizes revenue in accordance with Accounting Standards Codification (“ASC”) 606, the core principle of which is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled to receive in exchange for those goods or services. The Company recognizes revenue for its performance obligation associated with its contracts with customers at a point in time once products are shipped. Amounts collected from customers in advance of shipping products ordered are reflected as deferred revenue on the accompanying consolidated balance sheets. The Company’s standard terms are non-cancelable and do not provide for the right-of-return, other than for defective merchandise covered under the Company’s standard warranty. The Company has not historically experienced any significant returns or warranty issues. |
Fair Value of Financial Instruments | Fair Value of Financial Instruments Fair value of financial and non-financial assets and liabilities is defined as an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. The three-tier hierarchy for inputs used in measuring fair value, which prioritizes the inputs used in the methodologies of measuring fair value for assets and liabilities, is as follows: Level 1 — Quoted prices in active markets for identical assets or liabilities Level 2 — Observable inputs other than quoted prices in active markets for identical assets and liabilities Level 3 — Unobservable pricing inputs in the market Financial assets and financial liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurements. Our assessment of the significance of a particular input to the fair value measurements requires judgment and may affect the valuation of the assets and liabilities being measured and their categorization within the fair value hierarchy. The Company’s financial instruments consist of cash and cash equivalents, accounts receivable, and accounts payable. The carrying amount of these financial instruments approximates fair value due to their short-term maturity. The Company’s derivative liabilities were calculated using Level 2 assumptions on the issuance date via a Black-Scholes option pricing model whose assumptions are in line with the assumptions noted below in the warrant section. |
Income Taxes | Income Taxes Income taxes are accounted for in accordance with the provisions of ASC 740, Accounting for Income Taxes. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amounts that are more likely than not to be realized. |
Intangible Asset | Intangible Asset Intangible asset relates to the “Slinger” technology trademark, which the Company purchased on November 10, 2020. The trademark is amortized over its expected life of 20 years. Amortization expense for the year ended April 30, 2021 and 2020 was $2,730 and zero, respectively. The amount of amortization expense for each of the next five years will be approximately $5,800 per year. |
Long-Lived Assets | Long-Lived Assets In accordance with ASC 360-10, the Company evaluates long-lived assets for impairment whenever events or changes in circumstances indicate that their net book value may not be recoverable. When such factors and circumstances exist, the Company compares the projected undiscounted future cash flows associated with the related asset or group of assets over their estimated useful lives against their respective carrying amount. If those net undiscounted cash flows do not exceed the carrying amount, impairment, if any, is based on the excess of the carrying amount over the fair value based on the market value or discounted expected cash flows of those assets and is recorded in the period in which the determination is made. There was no impairment of long-lived assets identified during the year ended April 30, 2021 or 2020. |
Share-Based Payment | Share-Based Payment The Company accounts for share-based compensation in accordance with ASC 718, Compensation-Stock Compensation (ASC 718). Under the fair value recognition provisions of this topic, stock-based compensation cost is measured at the grant date based on the fair value of the award and is recognized as an expense on a straight-line basis over the requisite service period, which is the vesting period. |
Warrants | Warrants The Company grants warrants to key employees and executives as compensation on a discretionary basis. The Company also grants warrants in connection with certain note payable agreements and other key arrangements. The Company is required to estimate the fair value of share-based awards on the measurement date and recognize as expense that value of the portion of the award that is ultimately expected to vest over the requisite service period. Warrants granted in connection with ongoing arrangements are more fully described in Note 7: Note Payable and Note 9: Shareholders’ Deficit. The warrants granted during the year ended April 30, 2021 and 2020 were valued using a Black-Scholes option pricing model on the date of grant using the following assumptions: 2021 2020 Expected life in years 2 – 10 years 2 -10 years Stock price volatility 148% - 280% 121% - 144% Risk free interest rate 0.12% - 1.64% 0.36% - 2.43% Expected dividends 0% 0% |
Foreign Currency Translation | Foreign Currency Translation A portion of SBL’s operations are conducted in Israel and its functional currency is the Israeli Shekel, the Company’s operations of Slinger Bag Canada are conducted in its functional currency of Canadian Dollars, and the Company’s Slinger Bag UK operations are conducted in its functional currency of the British pound (GBP). The accounts of SBL, Slinger Bag Canada, and Slinger Bag UK have been translated into U.S. dollars (“USD”). Assets and liabilities are translated into USD at the applicable exchange rates at period-end. Shareholders’ equity is translated using historical exchange rates. Revenue and expenses are translated at the average exchange rates for the period. Any translation adjustments are included as foreign currency translation adjustments on the consolidated statements of operations and comprehensive loss. |
Earnings Per Share | Earnings Per Share Basic earnings per share are calculated by dividing income available to shareholders by the weighted-average number of common shares outstanding during each period. Diluted earnings per share are computed using the weighted average number of common and dilutive common share equivalents outstanding during the period. The Company had 6,921,299 and 8,137,859 common shares issuable as of April 30, 2021 and 2020, respectively, (see Note 5 and 6) which were not included in the calculation of diluted earnings per share as the effect is antidilutive. The Company also had outstanding notes payable convertible into zero and 7,465,811 shares of common stock as of April 30, 2021 and 2020, respectively, (see Note 6), outstanding warrants exercisable into 24,503,107 and 13,000,000 shares of common stock as of April 30, 2021 and 2020, respectively, and 21,786 and zero shares related to make-whole provisions as of April 30, 2021 and 2020, respectively, (see Note 7), which were excluded from the calculation of diluted earnings per share as the effect is antidilutive. As a result, the basic and diluted earnings per share are the same for each of the periods presented. |
Recent Accounting Pronouncements | Recent Accounting Pronouncements In December 2019, the FASB issued Accounting Standards Update (ASU), 2019-12, Simplifying the Accounting for Income Taxes Income Taxes Other recently issued accounting pronouncements did not, or are not believed by management to, have a material effect on the Company’s present or future consolidated financial statements. |
Summary of Significant Accoun_3
Summary of Significant Accounting Policies (Tables) | 12 Months Ended |
Apr. 30, 2021 | |
Accounting Policies [Abstract] | |
Summary of Warrants Granted Valuation using Black-Scholes Pricing Method | The warrants granted during the year ended April 30, 2021 and 2020 were valued using a Black-Scholes option pricing model on the date of grant using the following assumptions: 2021 2020 Expected life in years 2 – 10 years 2 -10 years Stock price volatility 148% - 280% 121% - 144% Risk free interest rate 0.12% - 1.64% 0.36% - 2.43% Expected dividends 0% 0% |
Income Taxes (Tables)
Income Taxes (Tables) | 12 Months Ended |
Apr. 30, 2021 | |
Schedule of Net Deferred Tax | Net deferred tax assets from operations in the US, using an effective tax rate of 21%, consisted of the following: April 30, April 30, 2021 2020 Deferred tax assets: Loss carryforwards $ 788,400 $ 301,000 Accrued payroll 333,700 - Related party accruals 194,400 79,000 Start-up costs 109,600 61,000 Other 17,900 - Valuation allowance (1,444,000 ) (441,000 ) Net deferred tax assets $ - $ - |
Schedule of Income Tax Provision | The income tax provision differs from the amount of income tax determined by applying the applicable statutory income tax rate to pretax loss due to the following for the years ended April 30, 2021 and 2020: April 30, April 30, 2021 2020 Income tax benefit based on book loss at US statutory rate $ (3,832,300 ) $ (1,273,000 ) Share-based compensation and shares for services 188,100 786,000 Debt discount amortization 79,100 15,000 Related party accruals 127,800 79,000 Start-up costs - 61,000 Interest expense 2,630,000 41,000 Meals and entertainment - 1,000 Loss on extinguishment of debt 636,400 - Accrued payroll 215,400 - Gain on change in fair value of derivatives (407,300) - Other 1,500 - Valuation allowance 361,300 290,000 Total income tax provision $ - $ - |
ISRAEL | |
Schedule of Net Deferred Tax | Net deferred tax assets from operations in Israel, using an effective tax rate of 23%, consisted of the following: April 30, April 30, 2021 2020 Deferred tax assets: Loss carryforwards $ 178,000 $ 384,000 Accrued expenses - 63,000 Start-up costs 13,000 - Research and development costs 113,000 23,000 Valuation allowance (304,000 ) (470,000 ) Net deferred tax assets $ - $ - |
Schedule of Income Tax Provision | The income tax provision differs from the amount of income tax determined by applying the applicable Israeli statutory income tax rate of 23% due to the following for the years ended April 30, 2021 and 2020: April 30, April 30, 2021 2020 Income tax provision (benefit) based on book income (loss) at Israeli statutory rate $ 80,000 $ (728,000 ) Debt discount amortization - 430,000 Related party accruals - 44,000 Travel expenses - 38,000 Research and development costs 113,000 23,000 Other non-deductible items - 9,000 Start-up costs 13,000 - Valuation allowance - 184,000 Loss carryforward (206,000 ) - Total income tax provision $ - $ - |
Organization and Basis of Pre_2
Organization and Basis of Presentation (Details Narrative) - USD ($) | Sep. 16, 2019 | Aug. 23, 2019 | Apr. 30, 2021 | Apr. 30, 2020 | Feb. 25, 2020 | Feb. 24, 2020 | Feb. 11, 2020 |
Common stock, shares authorized | 300,000,000 | 300,000,000 | 300,000,000 | 75,000,000 | |||
Stock split, description | four-to-one forward split of the outstanding shares of common stock | ||||||
Sole Shareholder of SBL [Member] | |||||||
Ownership percentage | 82.00% | ||||||
Number of shares owned | 20,000,000 | ||||||
Slinger Bag Americas Inc [Member] | |||||||
Ownership percentage | 100.00% | ||||||
Number of shares exchanged | 20,000,000 | ||||||
Slinger Bag Ltd [Member] | |||||||
Ownership percentage | 100.00% | ||||||
Stock Purchase Agreement [Member] | Slinger Bag Americas Inc [Member] | |||||||
Ownership percentage | 100.00% | ||||||
Number of shares issued for acquisition | 20,000,000 | ||||||
Number of shares issued for acquisition, value | $ 332,239 |
Going Concern (Details Narrativ
Going Concern (Details Narrative) - USD ($) | Apr. 30, 2021 | Apr. 30, 2020 |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | ||
Accumulated deficit | $ (28,823,273) | $ (10,228,513) |
Summary of Significant Accoun_4
Summary of Significant Accounting Policies (Details Narrative) - USD ($) | 12 Months Ended | |
Apr. 30, 2021 | Apr. 30, 2020 | |
Allowance for doubtful accounts | ||
Inventory finished goods | 1,591,826 | 663,750 |
Inventory component and replacement parts | 1,777,028 | 255,894 |
Capitalized duty and freight | 347,362 | |
Inventory reserve | $ 23,000 | |
Expected life for trademarks | 20 years | |
Amortization expense | $ 2,730 | 0 |
Amortization expenses of intangible asset year one | 5,800 | |
Amortization expenses of intangible asset year two | 5,800 | |
Amortization expenses of intangible asset year three | 5,800 | |
Amortization expenses of intangible asset year four | 5,800 | |
Amortization expenses of intangible asset year five | 5,800 | |
Impairment of long-lived assets | ||
Antidilutive securities earnings per share | 6,921,299 | 8,137,859 |
Warrants [Member] | ||
Antidilutive securities earnings per share | 24,503,107 | 13,000,000 |
Make-Whole Provisions [Member] | ||
Antidilutive securities earnings per share | 21,786 | 0 |
Notes Payable [Member] | ||
Antidilutive securities earnings per share | 0 | 7,465,811 |
Summary of Significant Accoun_5
Summary of Significant Accounting Policies - Summary of Warrants Granted Valuation using Black-Scholes Pricing Method (Details) - Warrant [Member] - Valuation Technique, Option Pricing Model [Member] | 12 Months Ended | |
Apr. 30, 2021 | Apr. 30, 2020 | |
Expected Life in Years [Member] | Minimum [Member] | ||
Measurement input, term | 2 years | 2 years |
Expected Life in Years [Member] | Maximum [Member] | ||
Measurement input, term | 10 years | 5 years |
Stock Price Volatility [Member] | Minimum [Member] | ||
Measurement input, rate | 148 | 121 |
Stock Price Volatility [Member] | Maximum [Member] | ||
Measurement input, rate | 280 | 144 |
Risk Free Interest Rate [Member] | Minimum [Member] | ||
Measurement input, rate | 0.12 | 0.36 |
Risk Free Interest Rate [Member] | Maximum [Member] | ||
Measurement input, rate | 1.64 | 2.43 |
Expected Dividends [Member] | ||
Measurement input, rate | 0 | 0 |
Intangible Asset (Details Narra
Intangible Asset (Details Narrative) - USD ($) | Nov. 10, 2020 | Apr. 30, 2021 |
Purchase of assets, shares | 35,000 | |
Shares issued in connection with purchase of trademark | $ 35,351 | $ 35,351 |
Warrants issued in connection with purchase of trademark | $ 50,232 | |
Trademark Assignment Agreement [Member] | ||
Trademark for cash | $ 30,000 | |
Purchase of assets, shares | 35,000 | |
Warrants purchase | 50,000 | |
Excercise price of warrants | $ 0.50 | |
Warrants term | 10 years | |
Shares issued in connection with purchase of trademark | $ 35,351 | |
Warrants issued in connection with purchase of trademark | 50,232 | |
Trademark purchase price | $ 115,583 |
Note Payable - Related Party (D
Note Payable - Related Party (Details Narrative) - USD ($) | Apr. 11, 2021 | Mar. 25, 2021 | Dec. 03, 2020 | Nov. 24, 2020 | Sep. 15, 2020 | Aug. 10, 2020 | Jul. 08, 2020 | May 12, 2020 | Feb. 28, 2020 | Dec. 13, 2019 | Dec. 11, 2019 | Jan. 06, 2019 | Apr. 30, 2021 | Apr. 30, 2021 | Apr. 30, 2020 | Sep. 07, 2020 | Jul. 03, 2020 | Jan. 06, 2020 | Dec. 03, 2019 | Oct. 01, 2019 |
Borrowings | $ 6,143,223 | $ 6,143,223 | $ 2,100,000 | |||||||||||||||||
Loss on extinguishment of debt | $ 1,501,914 | (3,030,495) | ||||||||||||||||||
Interest expense - related party | 608,668 | 171,918 | ||||||||||||||||||
Debt discount | 0 | 0 | 42,872 | |||||||||||||||||
Convertible note payable | 82,128 | |||||||||||||||||||
Note payable | $ 252,697 | $ 252,697 | ||||||||||||||||||
Shares issuable | 6,921,299 | 6,921,299 | 8,137,859 | |||||||||||||||||
Outstanding amount is net of total discounts | $ 76,777 | $ 76,777 | ||||||||||||||||||
Outstanding debt | 6,143,223 | 6,143,223 | ||||||||||||||||||
Accrued interest - related parties | $ 747,636 | $ 747,636 | $ 138,967 | |||||||||||||||||
Ontario Inc. [Member] | ||||||||||||||||||||
Borrowings | $ 1,820,000 | |||||||||||||||||||
Interest rate | 9.50% | |||||||||||||||||||
Number of stock issued | 1,216,560 | |||||||||||||||||||
Convertible note payable | $ 1,700,000 | |||||||||||||||||||
Note payable | $ 120,000 | |||||||||||||||||||
Shares issuable | 6,921,299 | 6,921,299 | ||||||||||||||||||
Former Shareholder [Member] | ||||||||||||||||||||
Borrowings | $ 3,600,000 | $ 3,600,000 | ||||||||||||||||||
Lender [Member] | ||||||||||||||||||||
Borrowings | $ 250,000 | $ 250,000 | ||||||||||||||||||
Interest rate | 95.00% | 24.00% | ||||||||||||||||||
Debt instrument maturity date | Sep. 15, 2021 | Aug. 10, 2021 | ||||||||||||||||||
Debt instrument extended maturity date | Sep. 1, 2021 | |||||||||||||||||||
Number of warrants issued to purchase common shares | 125,000 | 2,500,000 | ||||||||||||||||||
Warrants, exercise price | $ 0.001 | $ 0.001 | ||||||||||||||||||
Warrants, term | 10 years | 10 years | ||||||||||||||||||
Loss on extinguishment of debt | 1,999,487 | 0 | ||||||||||||||||||
Valuation of the warrants issued discounted | $ 70,130 | |||||||||||||||||||
Fair Value of Warrants | $ 97,473 | |||||||||||||||||||
Interest expense - related party | 43,615 | 0 | ||||||||||||||||||
Debt discount | 26,515 | 26,515 | ||||||||||||||||||
Lender [Member] | Interest Rate Reduction [Member] | ||||||||||||||||||||
Interest rate | 95.00% | |||||||||||||||||||
Related Party Debt Holder [Member] | ||||||||||||||||||||
Borrowings | $ 300,000 | |||||||||||||||||||
Interest rate | 9.50% | |||||||||||||||||||
Debt instrument maturity date | Nov. 24, 2021 | |||||||||||||||||||
Number of warrants issued to purchase common shares | 125,000 | |||||||||||||||||||
Warrants, exercise price | $ 0.001 | |||||||||||||||||||
Warrants, term | 10 years | |||||||||||||||||||
Valuation of the warrants issued discounted | 37,939 | $ 0 | ||||||||||||||||||
Fair Value of Warrants | $ 124,931 | |||||||||||||||||||
Debt discount | $ 88,201 | $ 50,262 | $ 50,262 | |||||||||||||||||
Loan Agreement [Member] | Former Shareholder [Member] | ||||||||||||||||||||
Borrowings | $ 1,000,000 | $ 200,000 | $ 700,000 | $ 500,000 | $ 200,000 | $ 500,000 | $ 500,000 | |||||||||||||
Interest rate | 24.00% | 24.00% | 24.00% | 24.00% | 24.00% | 12.00% | 12.00% | |||||||||||||
Debt instrument maturity date | Aug. 31, 2020 | Jan. 8, 2021 | Jul. 15, 2020 | Jan. 8, 2021 | ||||||||||||||||
Debt instrument extended maturity date | Jan. 8, 2021 | Jul. 3, 2021 | Sep. 1, 2021 | Sep. 1, 2021 | Sep. 1, 2021 | |||||||||||||||
Loan Agreement [Member] | Related Party [Member] | ||||||||||||||||||||
Borrowings | $ 1,000,000 | |||||||||||||||||||
Interest rate | 1.00% | |||||||||||||||||||
Debt instrument maturity date | Apr. 25, 2021 | |||||||||||||||||||
Outstanding debt | ||||||||||||||||||||
Amended and Restated Loan Agreement [Member] | ||||||||||||||||||||
Interest rate | 24.00% | |||||||||||||||||||
Debt instrument maturity date | Jul. 15, 2020 | |||||||||||||||||||
Debt instrument extended maturity date | Sep. 1, 2021 | |||||||||||||||||||
Purchase Order Financing Agreement [Member] | ||||||||||||||||||||
Borrowings | $ 1,900,000 | |||||||||||||||||||
Interest rate | 2.00% |
Convertible Notes Payable (Deta
Convertible Notes Payable (Details Narrative) - USD ($) | Apr. 11, 2021 | Dec. 03, 2020 | Sep. 04, 2020 | Mar. 02, 2020 | Feb. 11, 2020 | Nov. 20, 2019 | Sep. 11, 2019 | Jun. 02, 2019 | Apr. 30, 2021 | Apr. 30, 2020 | Jun. 02, 2020 | May 06, 2020 | Sep. 16, 2019 |
Convertible note payable | $ 125,000 | ||||||||||||
Common stock, shares issued | 27,642,828 | 24,749,354 | 1,216,560 | ||||||||||
Shares issuable | 6,921,299 | 8,137,859 | |||||||||||
Debt conversion converted instrument, value | $ 1,250,004 | $ 1,937,041 | |||||||||||
Amortization of debt discount | 376,506 | 1,565,174 | |||||||||||
Notes payable | 252,697 | ||||||||||||
Accrued interest | 4,274 | ||||||||||||
Induced conversion loss | 51,412 | ||||||||||||
Unamortized debt discount | 0 | 42,872 | |||||||||||
Convertible Note Payable Agreement [Member] | |||||||||||||
Convertible note payable | 125,000 | $ 125,000 | $ 125,000 | ||||||||||
Debt instrument interest rate | 12.00% | 12.00% | |||||||||||
Value of warrant | $ 566,667 | ||||||||||||
Debt conversion converted instrument, value | $ 53,571 | $ 566,667 | |||||||||||
Amount of conversion option | $ 358,855 | ||||||||||||
Amortization of debt discount | 206,061 | $ 1,493,939 | |||||||||||
Debt instrument maturity date | Feb. 11, 2021 | Nov. 20, 2020 | |||||||||||
Accrued interest | $ 4,274 | ||||||||||||
Debt conversion converted instrument, shares | 369,354 | ||||||||||||
Induced conversion loss | 51,412 | ||||||||||||
Convertible Note Payable Agreement [Member] | Derivative [Member] | |||||||||||||
Debt conversion converted instrument, value | $ 53,571 | ||||||||||||
Amortization of debt discount | 53,571 | ||||||||||||
Reclassification of derivative liability to additional paid-in capital | $ 53,571 | ||||||||||||
Convertible Note Payable Agreement [Member] | Debtholder [Member] | |||||||||||||
Options for debtholders conversion price percentage | 70.00% | 70.00% | |||||||||||
Convertible Note Payable Agreement [Member] | Mont-Saic Investments [Member] | |||||||||||||
Convertible note payable | $ 1,700,000 | $ 1,700,000 | |||||||||||
Debt instrument interest rate | 12.60% | ||||||||||||
Debt instrument maturity date, description | All outstanding amounts were due on the maturity date 360 days after the loan issue date. | ||||||||||||
Maximum percentage of payment on oustanding debt | 50.00% | ||||||||||||
Ownership percentage | 33.00% | ||||||||||||
Common stock, shares issued | 1,216,560 | ||||||||||||
Shares issuable | 6,921,299 | ||||||||||||
Debt conversion converted instrument, value | $ 120,000 | ||||||||||||
Notes payable | $ 1,820,000 | ||||||||||||
Convertible Note Payable Agreement [Member] | Mont-Saic Investments [Member] | Debtholder [Member] | |||||||||||||
Options for debtholders conversion price percentage | 75.00% | ||||||||||||
Warrant Assignment and Conveyance Agreement [Member] | Mont-Saic Investments [Member] | |||||||||||||
Ownership percentage | 33.00% | ||||||||||||
Value of warrant | $ 1,492,188 | ||||||||||||
Common stock, shares issued | 1,216,560 | ||||||||||||
Shares issuable | 6,921,299 | 8,137,859 | |||||||||||
Convertible Note Payable Agreement [Member] | |||||||||||||
Convertible note payable | $ 125,000 | ||||||||||||
Accrued interest | $ 8,466 | ||||||||||||
Debt conversion converted instrument, shares | 300,000 | ||||||||||||
February 2020 Convertible Note Payable Agreement [Member] | |||||||||||||
Convertible note payable | $ 1,700,000 | $ 1,825,000 | |||||||||||
Outstanding balance net of debt discounts | $ 0 | $ 248,933 |
Note Payable (Details Narrative
Note Payable (Details Narrative) - USD ($) | Apr. 15, 2021 | Apr. 11, 2021 | Feb. 02, 2021 | Dec. 24, 2020 | Dec. 15, 2020 | Mar. 16, 2020 | Apr. 30, 2021 | Apr. 30, 2020 | Jun. 30, 2020 | Mar. 02, 2020 |
Amortization of debt discount | $ 376,506 | $ 1,565,174 | ||||||||
Debt conversion converted instrument, value | $ 1,250,004 | 1,937,041 | ||||||||
Debt principal amount outstanding | 6,143,223 | |||||||||
Loss on extinguishment of debt | 1,501,914 | (3,030,495) | ||||||||
Derivative liability | 0 | $ 53,571 | ||||||||
Gain on change in fair value of derivatives | (1,939,639) | |||||||||
Valuation Technique, Option Pricing Model [Member] | ||||||||||
Derivative liability | $ 1,251,910 | |||||||||
Derivative liablity fair value | $ 14,513,903 | |||||||||
Loan Agreement [Member] | Mont-Saic Investments [Member] | ||||||||||
Note payable | $ 120,000 | |||||||||
Debt instrument interest rate | 12.60% | |||||||||
Promissory Note Payable [Member] | ||||||||||
Note payable | $ 500,000 | |||||||||
Debt instrument interest rate | 12.00% | |||||||||
Debt instrument maturity date | Mar. 16, 2022 | |||||||||
Number of warrants issued to purchase common shares | 500,000 | |||||||||
Options for debtholders conversion price percentage | 20.00% | 40.00% | ||||||||
Valuation of warrants issued | $ 112,990 | |||||||||
Amortization of debt discount | 35,542 | $ 6,965 | ||||||||
Debt conversion converted instrument, value | $ 1,500,000 | $ 500,000 | ||||||||
Debt instrument converted shares | 272,332 | 500,000 | ||||||||
Unamortized debt discount | 70,483 | |||||||||
Debt conversion description | On April 11, 2021, the Company and the lender entered into an agreement whereby the lender converted the promissory note into 272,332 shares of Company stock, which were issued to the lender at a 20% discount from the closing price of the stock on the day prior to the conversion. In addition to the discount, the agreement contains a guarantee that the aggregate gross sales of the shares by the lender will be no less than $1,500,000 over the next three years and if the aggregate gross sales are less than $1,500,000 the Company will issue additional shares of common stock to the lender for the difference between the total gross proceeds and $1,500,000. | |||||||||
Derivative liablity fair value | 1,229,851 | |||||||||
Gain on change in fair value of derivatives | 22,059 | |||||||||
Promissory Note [Member] | ||||||||||
Debt instrument maturity date | Apr. 30, 2021 | |||||||||
Promissory Note [Member] | Third Party [Member] | ||||||||||
Debt instrument interest rate | 2.25% | |||||||||
Debt instrument maturity date | Feb. 8, 2021 | |||||||||
Debt principal amount outstanding | $ 1,000,000 | |||||||||
Notes Payable [Member] | ||||||||||
Note payable | $ 2,000,000 | |||||||||
Debt instrument interest rate | 15.00% | |||||||||
Debt instrument maturity date | Apr. 14, 2023 | |||||||||
Number of warrants issued to purchase common shares | 2,200,000 | |||||||||
Amortization of debt discount | 10,477 | |||||||||
Unamortized debt discount | 1,989,523 | |||||||||
Derivative liablity fair value | 12,583,598 | |||||||||
Gain on change in fair value of derivatives | $ 1,917,580 | |||||||||
Warrant excercise price | $ 0.25 | |||||||||
Warrant description | The exercise price has customary anti-dilution protection for stock splits, mergers, etc. Additionally, the warrant contains a stipulation that the Company will guarantee the value of the shares sold will be no less, on average, than $1.50 per share through April 15, 2023. If the value is less than $1.50, the Company will issue additional shares of common stock to compensate for the shortfall. | |||||||||
Interest expense | $ 12,501,178 |
Related Party Transactions (Det
Related Party Transactions (Details Narrative) - USD ($) | Apr. 30, 2021 | Apr. 30, 2020 |
Outstanding notes payable | $ 6,220,000 | $ 2,100,000 |
Accrued interest - related party | 747,636 | 138,967 |
Due to related parties | 0 | 377,106 |
Related Party [Member] | ||
Recognized net sales | 615,584 | $ 0 |
Accounts receivable | $ 86,956 |
Stockholders' Deficit (Details
Stockholders' Deficit (Details Narrative) | Apr. 11, 2021USD ($)shares | Feb. 09, 2021USD ($)$ / sharesshares | Jan. 11, 2021shares | Dec. 15, 2020USD ($)shares | Nov. 24, 2020USD ($)shares | Nov. 10, 2020USD ($)shares | Oct. 29, 2020$ / sharesshares | Oct. 28, 2020USD ($)$ / sharesshares | Oct. 08, 2020USD ($) | Oct. 08, 2020shares | Sep. 04, 2020USD ($)shares | May 15, 2020USD ($)shares | May 06, 2020shares | Apr. 30, 2020$ / sharesshares | Mar. 16, 2020shares | Mar. 02, 2020USD ($) | Mar. 02, 2020USD ($)shares | Apr. 30, 2021USD ($)$ / sharesshares | Apr. 30, 2021USD ($)$ / sharesshares | Apr. 30, 2020USD ($)$ / sharesshares | Apr. 13, 2021shares | Feb. 25, 2020shares | Feb. 24, 2020shares | Sep. 16, 2019USD ($)shares |
Common stock, shares authorized | shares | 300,000,000 | 300,000,000 | 300,000,000 | 300,000,000 | 300,000,000 | 75,000,000 | ||||||||||||||||||
Common stock, par value | $ / shares | $ 0.001 | $ 0.001 | $ 0.001 | $ 0.001 | ||||||||||||||||||||
Common stock, shares issued | shares | 1,216,560 | 24,749,354 | 27,642,828 | 27,642,828 | 24,749,354 | |||||||||||||||||||
Common stock, shares outstanding | shares | 24,749,354 | 27,642,828 | 27,642,828 | 24,749,354 | ||||||||||||||||||||
Shares issued for conversion of convertible debt, shares | shares | 272,332 | 300,000 | 369,354 | |||||||||||||||||||||
Convertible notes payable | $ 125,000 | $ 125,000 | ||||||||||||||||||||||
Accrued interest | 4,274 | 4,274 | ||||||||||||||||||||||
Derivative liability | 53,571 | $ 53,571 | $ 0 | $ 0 | ||||||||||||||||||||
Forgiveness of net liabilities owed to former majority shareholder | $ 15,289 | |||||||||||||||||||||||
Number of warrants granted | shares | 112,990 | |||||||||||||||||||||||
Shares issued for services | 850,129 | |||||||||||||||||||||||
Shares issued for conversion of convertible debt | $ 238,449 | |||||||||||||||||||||||
Fair value of common stock | $ 1,250,004 | |||||||||||||||||||||||
Operating Expenses | 6,850,461 | $ 6,232,503 | ||||||||||||||||||||||
Shares issued in connection with purchase of trademark, shares | shares | 35,000 | |||||||||||||||||||||||
Shares issued in connection with purchase of trademark | $ 35,351 | $ 35,351 | ||||||||||||||||||||||
Shares issuable | shares | 8,137,859 | 6,921,299 | 6,921,299 | 8,137,859 | ||||||||||||||||||||
Third Party [Member] | ||||||||||||||||||||||||
Shares issued for conversion of convertible debt, shares | shares | 500,000 | |||||||||||||||||||||||
Shares issued for conversion of convertible debt | $ 500,000 | |||||||||||||||||||||||
Fair value of common stock | $ 500,000 | |||||||||||||||||||||||
Common Stock [Member] | ||||||||||||||||||||||||
Forgiveness of net liabilities owed to former majority shareholder | ||||||||||||||||||||||||
Shares issued for services, shares | shares | 569,582 | |||||||||||||||||||||||
Shares issued for services | $ 570 | |||||||||||||||||||||||
Shares issued in connection with purchase of trademark, shares | shares | 35,000 | |||||||||||||||||||||||
Shares issued in connection with purchase of trademark | $ 35 | |||||||||||||||||||||||
Vendor [Member] | ||||||||||||||||||||||||
Shares issued for services, shares | shares | 100,000 | 243,800 | ||||||||||||||||||||||
Vendor [Member] | General and Administrative Expense [Member] | ||||||||||||||||||||||||
Shares issued for services | $ 65,826 | |||||||||||||||||||||||
Vendor [Member] | Operating Expense [Member] | ||||||||||||||||||||||||
Shares issued for services | $ 114,000 | |||||||||||||||||||||||
Service Provider [Member] | ||||||||||||||||||||||||
Warrants, exercise price | $ / shares | $ 0.75 | |||||||||||||||||||||||
Warrants, term | 10 years | |||||||||||||||||||||||
Service Provider [Member] | Warrant [Member] | ||||||||||||||||||||||||
Number of warrants granted | shares | 400,000 | |||||||||||||||||||||||
Share based compensation expenses | $ 221,826 | |||||||||||||||||||||||
Three Members [Member] | As Compensation [Member] | ||||||||||||||||||||||||
Number of warrants granted | shares | 7,500 | |||||||||||||||||||||||
Warrants, exercise price | $ / shares | $ 0.001 | |||||||||||||||||||||||
Warrants, term | 10 years | |||||||||||||||||||||||
Share based compensation expenses | $ 48,502 | |||||||||||||||||||||||
Warrant issued for employees and officers compensation | shares | 43,107 | |||||||||||||||||||||||
Two Vendor [Member] | ||||||||||||||||||||||||
Shares issued for services, shares | shares | 100,000 | 46,087 | ||||||||||||||||||||||
Two Vendor [Member] | Marketing and Other Services [Member] | ||||||||||||||||||||||||
Common stock, shares issued | shares | 18,750 | 5,000 | ||||||||||||||||||||||
Operating Expenses | 43,294 | |||||||||||||||||||||||
Third Party Vendor [Member] | ||||||||||||||||||||||||
Number of common shares issued during period, shares | shares | 55,945 | |||||||||||||||||||||||
Shares issued for services | $ 30,000 | |||||||||||||||||||||||
Extinguishment of debt | 25,278 | |||||||||||||||||||||||
Fair value of common stock | 198,386 | |||||||||||||||||||||||
Prepaid and other assets | $ 39,750 | $ 26,500 | 26,500 | |||||||||||||||||||||
Operating Expenses | $ 146,608 | |||||||||||||||||||||||
Brand ambassadors [Member] | As Compensation [Member] | ||||||||||||||||||||||||
Number of common shares issued during period, shares | shares | 12,000 | |||||||||||||||||||||||
Warrants, exercise price | $ / shares | $ 0.001 | $ 0.001 | ||||||||||||||||||||||
Warrants, term | 10 years | 10 years | ||||||||||||||||||||||
Warrant issued for employees and officers compensation | shares | 60,000 | |||||||||||||||||||||||
Common stock percentage | 50.00% | |||||||||||||||||||||||
Brand ambassadors [Member] | Warrants [Member] | As Compensation [Member] | ||||||||||||||||||||||||
Share based compensation expenses | $ 59,838 | |||||||||||||||||||||||
Brand ambassadors [Member] | Common Stock [Member] | As Compensation [Member] | ||||||||||||||||||||||||
Share based compensation expenses | $ 98,457 | |||||||||||||||||||||||
Key Employees and Officers [Member] | As Compensation [Member] | ||||||||||||||||||||||||
Warrants, exercise price | $ / shares | $ 0.001 | $ 0.001 | ||||||||||||||||||||||
Warrants, term | 10 years | 10 years | ||||||||||||||||||||||
Share based compensation expenses | $ 3,741,746 | |||||||||||||||||||||||
Warrant issued for employees and officers compensation | shares | 12,500,000 | |||||||||||||||||||||||
Key Executives [Member] | As Compensation [Member] | ||||||||||||||||||||||||
Warrants, exercise price | $ / shares | $ 0.001 | |||||||||||||||||||||||
Warrant issued for employees and officers compensation | shares | 6,000,000 | |||||||||||||||||||||||
Key Executives [Member] | Warrants [Member] | As Compensation [Member] | Risk Free Interest Rate [Member] | ||||||||||||||||||||||||
Warrants measurement input | 0.76 | |||||||||||||||||||||||
Key Executives [Member] | Warrants [Member] | As Compensation [Member] | Stock Price Volatility [Member] | ||||||||||||||||||||||||
Warrants measurement input | 63 | |||||||||||||||||||||||
Non-US Warrant Holders [Member] | As Compensation [Member] | ||||||||||||||||||||||||
Warrants, exercise price | $ / shares | $ 0.001 | |||||||||||||||||||||||
Share based compensation expenses | $ 70,997 | |||||||||||||||||||||||
Warrant issued for employees and officers compensation | shares | 1,500,000 | |||||||||||||||||||||||
Agreement term | 3 years | |||||||||||||||||||||||
Market capitalization threshold | $ 100,000,000 | |||||||||||||||||||||||
Stock Purchase Agreement [Member] | ||||||||||||||||||||||||
Number of shares issued for acquisition, value | 332,239 | |||||||||||||||||||||||
Forgiveness of net liabilities owed to former majority shareholder | $ 15,289 | |||||||||||||||||||||||
Note Payable Agreement [Member] | Mont-Saic Investments [Member] | ||||||||||||||||||||||||
Number of common shares issued during period, shares | shares | 1,216,560 | |||||||||||||||||||||||
Warrant Assignment and Conveyance Agreement [Member] | Mont-Saic Investments [Member] | ||||||||||||||||||||||||
Common stock, shares issued | shares | 1,216,560 | |||||||||||||||||||||||
Number of common shares issued during period, shares | shares | 1,216,560 | |||||||||||||||||||||||
Equity ownership, percentage | 33.00% | |||||||||||||||||||||||
Value of warrant | $ 1,492,188 | |||||||||||||||||||||||
Shares issuable | shares | 6,921,299 | 6,921,299 | 8,137,859 |
Commitments And Contingencies (
Commitments And Contingencies (Details Narrative) - USD ($) | 12 Months Ended | |
Apr. 30, 2021 | Apr. 30, 2020 | |
Commitments and Contingencies Disclosure [Abstract] | ||
Rent expense | $ 8,400 | $ 2,800 |
Income Taxes (Details Narrative
Income Taxes (Details Narrative) - USD ($) | 12 Months Ended | |
Apr. 30, 2021 | Apr. 30, 2020 | |
Effective income tax rate, percentage | 21.00% | 21.00% |
Net operating loss carryforwards | $ 6,296,000 | $ 1,424,000 |
Imcome tax, penalties and interest | ||
ISRAEL | ||
Effective income tax rate, percentage | 23.00% | |
Net operating loss carryforwards | $ 774,000 | $ 1,671,000 |
Income Taxes - Schedule of Net
Income Taxes - Schedule of Net Deferred Tax (Details) - USD ($) | Apr. 30, 2021 | Apr. 30, 2020 |
Deferred tax assets (liabilities): Loss carryforwards | $ 788,400 | $ 301,000 |
Deferred tax assets (liabilities): Accrued payroll | 333,700 | |
Deferred tax assets (liabilities): Related party accruals | 194,400 | 79,000 |
Deferred tax assets (liabilities): Start-up costs | 109,600 | 61,000 |
Deferred tax assets (liabilities): Inventory reserve | 17,900 | |
Deferred tax assets (liabilities): Other | 45,000 | |
Valuation allowance | (1,444,000) | (441,000) |
Net deferred tax assets | ||
ISRAEL | ||
Deferred tax assets (liabilities): Loss carryforwards | 178,000 | 384,000 |
Deferred tax assets (liabilities): Start-up costs | 13,000 | |
Deferred tax assets (liabilities): Accrued expenses | 63,000 | |
Deferred tax assets (liabilities): Research and development costs | 113,000 | 23,000 |
Valuation allowance | (304,000) | (470,000) |
Net deferred tax assets |
Income Taxes - Schedule of Inco
Income Taxes - Schedule of Income Tax Provision (Details) - USD ($) | 12 Months Ended | |
Apr. 30, 2021 | Apr. 30, 2020 | |
Income tax benefit based on book loss at US statutory rate | $ (3,832,300) | $ (1,273,000) |
Stock-based compensation and shares for services | 188,100 | 786,000 |
Debt discount amortization | 79,100 | 15,000 |
Related party accruals | 127,800 | 79,000 |
Start up costs | 61,000 | |
Interest expense | 2,630,000 | 41,000 |
Meals and entertainment | 1,000 | |
Loss on extinguishment of debt | 636,400 | |
Accrued payroll | 215,400 | |
Gain on change in fair value of derivatives | (407,300) | |
Other non-deductible items | 1,500 | |
Valuation allowance | 361,300 | 290,000 |
Total income tax provision | ||
ISRAEL | ||
Income tax benefit based on book loss at US statutory rate | 80,000 | (728,000) |
Debt discount amortization | 430,000 | |
Related party accruals | 44,000 | |
Start up costs | 13,000 | |
Accrued payroll | 38,000 | |
Research and development costs | 113,000 | 23,000 |
Other non-deductible items | 9,000 | |
Valuation allowance | 184,000 | |
Loss carryforward | (206,000) | |
Total income tax provision |
Subsequent Events (Details Narr
Subsequent Events (Details Narrative) - USD ($) | Jul. 21, 2021 | Jun. 23, 2021 | May 26, 2021 | Jul. 31, 2021 | Oct. 02, 2021 | Jul. 23, 2021 | Apr. 30, 2021 | Apr. 30, 2020 |
Borrowings | $ 6,143,223 | $ 2,100,000 | ||||||
Debt Instrument face amount | $ 6,143,223 | |||||||
Subsequent Event [Member] | ||||||||
Number of stock issued | 600,000 | |||||||
Hold back percentage | 10.00% | |||||||
Subsequent Event [Member] | Related Party [Member] | ||||||||
Borrowings | $ 500,000 | $ 500,000 | ||||||
Interest rate | 12.00% | 12.00% | ||||||
One Vendor and Two Employees [Member] | Subsequent Event [Member] | Marketing and Other Services [Member] | ||||||||
Shares issued for services, shares | 68,965 | |||||||
Six Brand Ambassadors [Member] | Subsequent Event [Member] | ||||||||
Shares issued for services, shares | 90,937 | |||||||
Loan Agreement [Member] | Subsequent Event [Member] | ||||||||
Interest rate | 15.00% | |||||||
Debt Instrument face amount | $ 2,000,000 | |||||||
Proceeds from line of credit | $ 300,000 | |||||||
Loan Agreement [Member] | Related Party Lender [Member] | Subsequent Event [Member] | ||||||||
Borrowings | $ 6,220,000 | |||||||
Number of stock issued | 1,636,843 | |||||||
Membership Interest Purchase Agreement [Member] | Subsequent Event [Member] | ||||||||
Number of stock issued | 540,000 | |||||||
Membership interest purchase agreement, description | the Company entered into a membership interest purchase agreement ("MIPA") with Charles Ruddy (the "Seller") to acquire a 100% ownership stake in Foundation Sports Systems, LLC ("Foundation Sports") in exchange for 1,000,000 shares of common stock of the Company to be issued to the Seller and two other Foundation Sports employees in three tranches (the "Purchase Price"): (i) 600,000 shares of common stock on the closing date, 200,000 shares of common stock on the first anniversary of the closing date and (iii) 200,000 shares of common stock on the second anniversary of the closing date (collectively, the "Shares"), provided that 10% of the Shares of each tranche will be held back by the Company and not delivered to the recipients for a period of 12 months from the date of their issuance. | |||||||
Hold back shares | 60,000 |